Halaman 2 - Osteosarkoma Dokter Terbaik di Turquia - TOP-28 dokter

Assoc. Prof. Murat Ayhan berspesialisasi dalam perawatan lanjutan untuk kanker tulang, termasuk imunoterapi inovatif dan terapi target di Rumah Sakit Liv Vadistanbul.

• Associate Professor Onkologi Medis dengan penelitian ekstensif dalam perawatan kanker
• Peserta aktif dalam uji klinis internasional untuk kanker payudara, paru-paru, dan kolorektal
• Penulis beberapa publikasi medis dan bab buku tentang onkologi
• Anggota European Society of Medical Oncology (ESMO) dan Turkish Society of Medical Oncology (TTOD)

Dr. Sokucu berspesialisasi dalam pengobatan osteosarkoma dengan pengalaman ortopedi lebih dari 17 tahun, termasuk penelitian tentang tumor tulang dan deformitas.

• Tersertifikasi oleh European Board of Orthopaedics and Traumatology
• Mempublikasikan berbagai studi tentang osteoma osteoid dan teknik pemanjangan tulang
• Anggota fakultas di Departemen Ortopedi Universitas Aydın Istanbul
• Anggota AO Turki dan FEBOT untuk praktik ortopedi tingkat lanjut

Associate Professor Dr. Emrah Eraslan mengkhususkan diri dalam onkologi medis dengan fokus pada osteosarkoma di Rumah Sakit Swasta Koru Ankara.

• Pengalaman lebih dari 15 tahun di bidang penyakit dalam dan onkologi medis
• Menjalani pelatihan di Rumah Sakit Pendidikan dan Penelitian Onkologi Dr. Abdurrahman Yurtaslan Ankara
• Menerbitkan berbagai makalah penelitian yang berkontribusi pada bidang onkologi
• Associate professor saat ini dengan praktik klinis aktif

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.